Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial Hypercholesterolemia Efficacy of LapaquistatAcetate Co-Administered With Current Lipid-Lowering Treatment on Blood Choles ...
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 or Placebo When Co-administered With Current Lipid-lowering Therapy in Subjects With Homozygous Familial Hypercholesterolemia. A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 ...
Hypercholesterolemia
Drug: Lapaquistat acetate and current lipid-lowering treatment;Drug: Current lipid-lowering treatment Drug: Lapaquistatacetate and current lipid-lowering treatment;Drug: Current lipid-lowering treatment ...
Takeda
NULL
Terminated
8 Years
N/A
Both
44
Phase 3
United States;Canada;France;Israel;Poland;United Kingdom